DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Evercore ISI Group Upgrades bluebird bio to Outperform, Raises Price Target to $100

Evercore ISI Group analyst Joshua Schimmer upgrades bluebird bio (NASDAQ:BLUE) from In-Line to Outperform and raises the price target from $86 to $100.

Benzinga · 02/03/2020 11:34

Evercore ISI Group analyst Joshua Schimmer upgrades bluebird bio (NASDAQ:BLUE) from In-Line to Outperform and raises the price target from $86 to $100.